ArticleCureus2024
Iron Deficiency and Renal Phosphate Handling: The Role of Maximal Tubular Reabsorption of Phosphate Normalized to Glomerular Filtration Rate (TmP/GFR) in Proximal Tubular Dysfunction.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimPhosphate dysregulation is often associated with chronic kidney disease (CKD), and recent studies suggest that it may also be present in non-CKD patients with systemic conditions including iron deficiency anemia. This study aimed to evaluate the relationship between iron deficiency parameters (total iron-binding capacity {TIBC}, hemoglobin, and serum ferritin) and markers of proximal tubular dysfunction (the maximal tubular reabsorption of phosphate normalized to glomerular filtration rate {TmP/GFR} and tubular reabsorption of phosphate {TRP}) in non-CKD patients with iron deficiency anemia.
methodsThis was a hospital-based analytical cross-sectional study conducted in the outpatient department and/or inpatient wards of the Department of Internal Medicine, Swaroop Rani Nehru (SRN) Hospital associated with Moti Lal Nehru (MLN) Medical College, Prayagraj, Uttar Pradesh, India, between July 2023 and August 2024.
resultsThis study analyzed 40 anemic patients without CKD, with a mean age of 33.9 years. Most participants (n=24, 60%) were aged 18-35 years, and the majority (n=27, 67.5%) were female. Peripheral smear analysis revealed that 72.5% (n=29) had microcytic hypochromic anemia. Hemoglobin levels averaged 7.7 g/dL, serum iron was 91.0 µg/dL, total iron-binding capacity (TIBC) was 316.3 µg/dL, and serum ferritin was 199.7 ng/mL. Phosphate handling was assessed with TmP/GFR and tubular reabsorption of phosphate (TRP) showing mean values of 4.1 mg/dL and 99.2%, respectively. This study found that TmP/GFR had a significant positive correlation with TIBC (r=0.402, p=0.010), but non-significant negative correlations with hemoglobin and serum iron. TRP was negatively correlated with hemoglobin and serum ferritin, but not significantly. Among patients with microcytic hypochromic anemia, 55.2% (n=16) had increased TmP/GFR, and 61.1% (n=20) of patients with iron deficiency anemia exhibited increased TmP/GFR. Regression analysis revealed that TIBC significantly predicted TmP/GFR (p=0.022), indicating that higher TIBC values are associated with increased TmP/GFR, suggesting a potential link between iron metabolism and renal phosphate handling.
conclusionHigher TIBC levels were associated with increased TmP/GFR, suggesting that iron deficiency anemia may influence proximal tubular function. The findings emphasize the importance of considering renal phosphate handling in patients with iron deficiency anemia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.